Hidefumi Kinoshita（Kinki/Osaka）
Professor and Chair, Director of Clinical Department
We are pioneers in laparoscopic and robotic surgery, equipped with two different robotic surgical systems, da Vinci and Hinotori, and we provide high-quality minimally invasive procedures.
In addition to robot-assisted surgery, we offer laser therapy for benign prostatic hyperplasia (BPH) using multiple advanced laser devices, ensuring appropriate endoscopic treatments. For prostate biopsy, we perform MRI-fusion guided biopsy.
- Clinical department/Main areas of expertise
- Specialized area
-
- Diagnosis, Surgery, and Pharmacotherapy for Urogenital (Genitourinary) Cancers
Benign Prostatic Hyperplasia (BPH) Detail
- Diagnosis, Surgery, and Pharmacotherapy for Urogenital (Genitourinary) Cancers
- surgery
- Minimally Invasive Surgery for Genitourinary Cancers
Robotic Minimally Invasive and High-Precision Surgery (especially for Prostate Cancer and Kidney Cancer)
Laser Therapy for Benign Prostatic Hyperplasia (BPH)
- Qualifications/Academia/Position
-
- Board-Certified Urologist / Training Supervisor, The Japanese Urological Association (JUA)
- Certified Endoscopic Laparoscopic Surgeon in Urology, The Japanese Urological Association (JUA) / Japanese Society of Endourology (JSE)
- Board-Certified Endocrinologist, The Japan Endocrine Society (JES)
- Board-Certified Clinical Geneticist, The Japan Society of Human Genetics (JSHG)
- Board-Certified Oncologist, Japanese Board of Cancer Therapy (JBCT)
- Core Examination Committee Member, Endoscopic and Laparoscopic Urological Surgery Certification System, Japanese Society of Endourology (JSE)
- Da Vinci Surgery Proctor (Partial Nephrectomy, Radical Prostatectomy)
- Certified Proctor in Urologic hinotori Robotic-Assisted Surgery
- Examination Committee Member, Endoscopic Surgical Skill Qualification System, Japan Society for Endoscopic Surgery (JSES)
- The Japanese Urological Association (JUA)
- Japanese Society of Endourology and Robotics (JSER)
- Japanese Society for Cancer Therapy (JSCT)
- Japanese Urological Association for Oncology (JUOA)
- Japanese Society for Endoscopic Surgery(JSES)
- Japan Society of Human Genetics(JSHG)
- Japan Endocrine Surgery Society (JSES)
- Councilor, Japanese Society of Endourology and Robotics (JSER)
- Japanese Society of Cancer Therapy
- Board Member, Japanese Urological Association for Oncology
- Affiliated hospital
- Kansai Medical University Hospital
- Website
- https://hp.kmu.ac.jp/
- location
-
〒573-1191
2-3-1 Shinmachi, Hirakata City Google Map Map
- Biography
-
- 1988年
- Graduated from Kyoto University, Faculty of Medicine
- 1988年
- Resident, Department of Urology, Kyoto University Hospital
- 1990年
- Staff Physician, Department of Urology, Kurashiki Central Hospital
- 1996年
- Research Fellow, University of Wisconsin–Madison
- 1999年
- Staff Physician, Department of Urology, Osaka Red Cross Hospital
- 2000年
- Assistant, Department of Urology, Kyoto University (currently Assistant Professor)
- 2003年
- Lecturer, Department of Urology, Kyoto University
- 2004年
- Associate Professor, Department of Nephro-Urology, Kansai Medical University
- 2014年
- Professor, Kansai Medical University Hospital
- 2021年
- Professor, Department of Nephro-Urology, Kansai Medical University
- 2022年
- Director, Community Medical Center, Kansai Medical University
- 2022年
- Director, Department of Regional Medical Cooperation, Kansai Medical University Hospital
- 2023年
- Director, Center for Robotic Surgery Promotion, Kansai Medical University Hospital
- paper
-
- Photodynamic Diagnosis-Guided Ureteroscopic Laser Ablation of Upper Urinary Tract Urothelial Carcinoma: Phase 2, Open-Label, Single-Arm Trial Ann Surg Oncol . 2025 Jan;32(1):35-38.
- The impact of the number of prior androgen receptor pathway inhibitors before cabazitaxel treatment in patients with metastatic castration-resistant prostate cancer "Jpn J Clin Oncol . 2025 Feb 23:hyaf034."
- Pathological Analysis of False-Positive Samples in Photodynamic Diagnosis of Bladder Cancer According to a History of Intravesical Bacillus Calmette-Guérin Therapy "Int J Urol . 2025 Mar 26. "
- Impact of LAG-3/FGL1 pathway on immune evasive contexture and clinical outcomes in advanced urothelial carcinoma "J Immunother Cancer . 2024 Jul 23;12(7):e009358. "
- Diagnostic performance of photodynamic diagnosis with oral 5-aminolevulinic acid for upper tract- and bladder urothelial carcinoma: a single-centre, retrospective analysis "World J Urol . 2024 Jul 10;42(1):389."
- Trifecta outcomes of robotic partial nephrectomy in obese patients: A comparison of body mass index <25, 25 to <30, and ≥30 "Int J Urol . 2024 Oct;31(10):1108-1113."
- Prevalence and risk factors for overactive bladder symptoms in patients with artificial urinary sphincter "Sci Rep . 2024 Sep 2;14(1):20332. "
- The optimal stent pusher position to achieve successful ureteral stent insertion under fluoroscopic guidance "Asian J Urol . 2024 Apr;11(2):311-315."
- Efficacy of immune checkpoint inhibitor combination therapy prior to nephrectomy in advanced renal cell carcinoma: A retrospective pilot study "BJUI Compass . 2024 Aug 15;5(10):957-960. "
- Comparison of the efficacy of a pulsed thulium YAG laser versus a holmium YAG laser on dusting lithotripsy: In vitro analysis using an optical motion capture system "Int J Urol . 2024 Nov;31(11):1288-1290. "
- book
-
- Clinical Practice Manual for Primary Aldosteronism, 4th Revised Edition pp.148–151 Shindan to Chiryo Sha, Inc. (Diagnosis and Treatment Publishing Company) 2024 Takizawa
- All About Perioperative Management in Urology, 3rd Edition, Vol. 3 pp.116–121 Medical View Co., Ltd. 2023 Taniguchi
- Smith's textbook of Endourology 4 2 1278-1291 Wiley Blackwell 2019 Matsuda T, Kawasaki Y, Miyajima A
- Endourology Progress 1 75-80 Springer 2019 Inoue T
- Urological Surgery Next, Vol. 1: Laparoscopic Surgery, Part 1 pp.106–110 Medical View Co., Ltd. 2018 Yoshida, Takayasu, Matsuda